TOP GLOVE 'TURNED A CORNER' AFTER 14 MONTHS OF HUMBLING, VALUABLE LESSONS — CHAIRMAN
TOP GLOVE EXPECTS ‘HEADWINDS’ AS SPEEDY VACCINATION DAMPS PRICES
END OF ‘SUPER PROFITS’? SHARES OF TOP MEDICAL GLOVE MAKER FALL AS COVID-INDUCED DEMAND EASES
TOP GLOVE SAYS READY TO FACE EXPECTED HEADWINDS
TOP GLOVE SET TO RESUME EXPORTS TO US AS EARLY AS END-SEPTEMBER
WITH LESSONS LEARNT FROM US ACTION, TOP GLOVE AIMS HIGHER
TOP GLOVE 4Q EARNING HIT BY WEAKER ASPS, COSTS
TOP GLOVE 4Q NET PROFIT SLIPS BUT FULL YEAR AT RM7.87B
TOP GLOVE 4Q NET PROFIT SINKS 70% Q-O-Q AND 48% Y-O-Y TO RM608M, DRAGGED BY LOWER SALES VOLUME, ASPS ON NORMALISED DEMAND